GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » Cyclically Adjusted Book per Share

JCR Pharmaceuticals Co (TSE:4552) Cyclically Adjusted Book per Share : 円329.13 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

JCR Pharmaceuticals Co's adjusted book value per share for the three months ended in Dec. 2024 was 円431.545. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円329.13 for the trailing ten years ended in Dec. 2024.

During the past 12 months, JCR Pharmaceuticals Co's average Cyclically Adjusted Book Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of JCR Pharmaceuticals Co was 11.10% per year. The lowest was 4.20% per year. And the median was 7.45% per year.

As of today (2025-05-29), JCR Pharmaceuticals Co's current stock price is 円455.00. JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was 円329.13. JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio of today is 1.38.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of JCR Pharmaceuticals Co was 17.23. The lowest was 1.28. And the median was 7.65.


JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Chart

JCR Pharmaceuticals Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 220.26 241.97 271.75 302.33 -

JCR Pharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 302.33 310.86 318.72 329.13 -

Competitive Comparison of JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio falls into.


;
;

JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JCR Pharmaceuticals Co's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=431.545/110.7000*110.7000
=431.545

Current CPI (Dec. 2024) = 110.7000.

JCR Pharmaceuticals Co Quarterly Data

Book Value per Share CPI Adj_Book
201503 205.936 97.900 232.861
201506 206.935 98.400 232.802
201509 211.692 98.500 237.912
201512 213.820 98.100 241.283
201603 212.741 97.900 240.556
201606 207.711 98.100 234.389
201609 211.200 98.000 238.570
201612 213.295 98.400 239.957
201703 218.363 98.100 246.410
201706 219.361 98.500 246.531
201709 215.645 98.800 241.618
201712 218.313 99.400 243.131
201803 222.251 99.200 248.016
201806 221.617 99.200 247.308
201809 231.631 99.900 256.672
201812 233.046 99.700 258.758
201903 249.048 99.700 276.526
201906 246.824 99.800 273.782
201909 252.344 100.100 279.066
201912 256.410 100.500 282.434
202003 262.648 100.300 289.882
202006 264.903 99.900 293.541
202009 269.874 99.900 299.050
202012 281.478 99.300 313.793
202103 310.472 99.900 344.037
202106 314.849 99.500 350.289
202109 378.716 100.100 418.820
202112 398.495 100.100 440.693
202203 411.136 101.100 450.176
202206 410.142 101.800 445.999
202209 409.019 103.100 439.170
202212 420.453 104.100 447.110
202303 418.037 104.400 443.263
202306 422.421 105.200 444.506
202309 455.632 106.200 474.938
202312 445.926 106.800 462.210
202403 450.114 107.200 464.810
202406 443.445 108.200 453.691
202409 451.820 108.900 459.288
202412 431.545 110.700 431.545

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


JCR Pharmaceuticals Co  (TSE:4552) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

JCR Pharmaceuticals Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=455.00/329.13
=1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of JCR Pharmaceuticals Co was 17.23. The lowest was 1.28. And the median was 7.65.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


JCR Pharmaceuticals Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of JCR Pharmaceuticals Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


JCR Pharmaceuticals Co Business Description

Traded in Other Exchanges
Address
3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.

JCR Pharmaceuticals Co Headlines

No Headlines